Ezetimibe and vascular endothelial function.
スポンサーリンク
概要
- 論文の詳細を見る
Hypercholesterolemia is a major risk factor for cardiovascular diseases that has been managed mostly with 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) that suppress de novo cholesterol synthesis in the liver. Statins also have beneficial pleiotropic effects on the atherosclerotic process that are independent of their ability to lower lipid values. However, the levels of low-density lipoprotein cholesterol (LDL-C) in most hypercholesterolemic patients at high risk for cardiovascular disease do not reach the goals proposed by guidelines even when prescribed with statins. Ezetimibe is a new lipid-lowering agent that blocks the intestinal absorption of dietary and biliary cholesterol and reduces LDL-C levels, especially when combined with statins. However, its effect on cardiovascular events remains unknown. We reviewed the effects of ezetimibe on cardiovascular diseases, in particular, vascular endothelial function, which is initially impaired during the atherogenetic process and is an important predictor of cardiovascular events. The simultaneous inhibition of cholesterol synthesis by statin and of cholesterol absorption by ezetimibe might retard the atherogenetic process. These effects are considered to be mainly mediated by lipid lowering. However, further studies should elucidate the mechanism of the anti-atherosclerotic effects induced by ezetimibe; for instance, whether or not it directly affects atherogenesis independently from its lipid-lowering effects.
論文 | ランダム
- 7・1・3 管内流(7・1 非圧縮流,7.流体工学,機械工学年鑑)
- 自宅退院の現状と課題(口述発表17,青森県の保健・医療・福祉における包括ケアの発展をめざして,第3回青森県立保健大学学術研究集会抄録)
- WATER MITES OF THE GENUS HYGROBATES (ACARI: HYDRACHNIDIA: HYGROBATES) FROM JAPAN(Taxonomy and Systematics,Abstracts of papers presented at the 75^ Annual Meeting of the Zoological Society of Japan)
- 12.泌尿器科開設三年間の患者の動向について(第731回千葉医学会例会・第44回千葉泌尿器科集談会)
- 治療を受ける患者、生活する人間としての2つの側面--東京都済生会中央病院 (特集 ベッドサイドにおける情報収集の極意) -- (事例 朝、昼、夕、夜における情報収集)